Reaction

Hypoprolactinaemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 51 reports · 2 co-occurring drugs

As of the last recalculation, Hypoprolactinaemia appears in 51 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ARIPIPRAZOLE ORAL (PRR 565.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Aripiprazole Oral27565.2565.5
Aripiprazole Orally Disintegrating27565.2565.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.